The Best Compounded GLP-1 Telehealth Providers, Compared

Compounded GLP-1 medications are produced by FDA-registered compounding pharmacies and contain the same active ingredient (semaglutide or tirzepatide) as the brand-name FDA-approved versions. They are not FDA-approved as a finished drug product, which is a real regulatory distinction. Safety in practice depends on the specific compounding pharmacy: PCAB-accredited 503A pharmacies and FDA-registered 503B outsourcing facilities operate to higher standards than non-accredited shops. The honest framing is that compounded GLP-1 is not riskier in principle than brand-name when sourced from a quality-controlled pharmacy, but the burden of vetting that pharmacy is on you (or on the telehealth provider you trust to vet it).

Compounded GLP-1 typically runs $99-$400/month all-inclusive vs the $1,000+/month list price of brand-name Wegovy or Zepbound without insurance. The price gap reflects three things: compounding pharmacies don't pay the manufacturer's R&D and FDA-approval cost recovery, telehealth platforms operate with thinner overhead than traditional clinics, and competitive pricing is the wedge that built the category in the first place. With commercial insurance covering branded Wegovy or Zepbound plus a manufacturer savings card, the branded path can drop to $0-$25/month effective cost, which is the only price floor that beats compounded.

Yes, but with narrower exemptions. Semaglutide was removed from the FDA shortage list in February 2025 and tirzepatide in late 2024, which limited the broad shortage-based compounding exemption that had powered the category through 2024. Compounded GLP-1 remains legal for patients with documented medical need, allergies to inactive ingredients in the brand-name formulation, or other personalization that requires a compounded preparation. The FDA has been specifically enforcing against telehealth marketing that implies compounded GLP-1 is equivalent to the brand-name approved products, which is a marketing constraint rather than a legality constraint.

Check three independent signals: LegitScript Healthcare Merchant certification (required for Google and Meta advertising), BBB profile rating and accreditation tenure, and FDA warning-letter database for the operating entity. None of those alone proves a provider is trustworthy, but if all three point the same direction, you have a reasonable baseline. We also weight whether the compounding pharmacy is named per fill, whether per-batch certificates of analysis are published, and whether cancellation requires a phone call vs an in-app flow.

If you have commercial insurance with weight-loss coverage and a manufacturer savings card available, the branded path via a platform like Ro can drop to $0-$25/month effective cost, which beats every compounded option. If you don't have insurance covering Wegovy or Zepbound, compounded GLP-1 through a vetted provider is typically the better cash-pay path; expect $99-$400/month depending on medication and form. The break-even calculation is whether your insurance plus savings card actually approves Wegovy for you (which has gotten harder in 2025-2026), and whether the prior-authorization friction is worth the cost difference.

Injectable compounded semaglutide and tirzepatide are the same delivery route as the brand-name injectables (subcutaneous weekly), and clinical evidence on the injectable form is well-established. Oral compounded forms (tablets or troches) are a relatively new product line and the clinical evidence base for oral compounded versions is meaningfully thinner than for injectables. Henry Meds is among the few cohort providers offering oral tirzepatide tablets; if you specifically want oral, options narrow. We treat oral compounded GLP-1 as more experimental than injectable, even though both use the same active ingredient.

Every provider on the site is scored on the same six-dimension rubric: licensure (20%), accreditation (20%), transparency (20%), product quality (15%), pricing (15%), and customer service (10%). The full methodology, including how each verification is sourced and what counts as a flagged signal, is at /methodology/provider-vetting. We never accept payment in exchange for a higher score, and any affiliate relationship is disclosed on the provider's profile.